跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Reagila - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Reagila
Approved
STANDARD
Reagila
Chemical Works of Gedeon Richter
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
99013b9fe2b55e5b
Company
Chemical Works of Gedeon Richter
Type
Standard
Approval Details
Approval Id
99013b9fe2b55e5b
Drug Approval Philippines Name
Reagila
Product Name
Reagila
Registration Number
DR-XY48935
Brand Name
Reagila
Generic Name
Cariprazine (as hydrochloride)
Dosage Form
Capsule
Dosage Strength
1.5 mg
Manufacturer
Chemical Works of Gedeon Richter
Importer
Aspen Philippines Inc
Issuance Date
24 November 2023
Expiry Date
24 November 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
99013b9fe2b55e5b
Type
Standard
Back to Philippines FDA Approvals